About Pfizer
Pfizer is a company based in New York (United States) founded in 1849. Pfizer has raised $8 million across 11 funding rounds from investors including Gates Foundation, European Union and Tekla Capital Management. The company has 1,770 employees as of March 31, 2024. Pfizer has completed 43 acquisitions, including Alacer, Allergan and Amplyx Pharmaceuticals. Pfizer operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter New York, United States
- Employees 1770 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pfizer Limited
-
Annual Revenue
$266.99 M (USD)4.04as on Mar 31, 2025
-
Net Profit
$89.89 M (USD)39.23as on Mar 31, 2025
-
EBITDA
$88.72 M (USD)15.82as on Mar 31, 2025
-
Total Equity Funding
$8 M (USD)
in 11 rounds
-
Latest Funding Round
$117.44 M (USD), Grant
Jun 27, 2023
-
Investors
Gates Foundation
& 4 more
-
Employee Count
1770
as on Mar 31, 2024
-
Investments & Acquisitions
Alacer
& 42 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Pfizer
Pfizer is a publicly listed company on the NSE with ticker symbol PFIZER in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Pfizer
Unlock access to complete
Unlock access to complete
Leadership Team
383 people
Software Development Team
297 people
Senior Team
99 people
Sales and Marketing
86 people
Product Management Team
74 people
Operations Team
73 people
Human Resources and Administration
43 people
Legal and Compliance
37 people
Unlock access to complete
Funding Insights of Pfizer
Pfizer has successfully raised a total of $8M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $117.44 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pfizer
Pfizer has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, European Union and Tekla Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm focused on life science and healthcare companies
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Economic development in Michigan is advanced by the foundation.
|
Locked | Locked | Locked |
Investor details for Pfizer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pfizer
Pfizer has strategically engaged in corporate development activities, having acquired 43 companies. Notable acquisitions include Alacer, Allergan and Amplyx Pharmaceuticals.
Investment portfolio details for Pfizer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for neurological and neuropsychiatric diseases are developed.
|
Locked | Locked | 2022 | Locked | |
|
Biopharmaceuticals for obesity and metabolic diseases are developed.
|
Locked | Locked | 2022 | Locked | |
|
Limited information is available on Meridica's core activities.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Pfizer
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Pfizer
Detailed financials for Pfizer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pfizer Comparisons
Peer comparison for Pfizer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pfizer
Pfizer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
Detailed competitors of Pfizer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pfizer
Complete news archive for Pfizer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pfizer
Pfizer was founded in 1849 and raised its 1st funding round 160 years after it was founded.
Pfizer is headquartered in New York, United States. It is registered at New York, New York, United States.
Albert Bourla is the current CEO of Pfizer.
Pfizer is a funded company, having raised a total of $8M across 11 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Pfizer is 1,770.
Annual revenue of Pfizer is $266.99M as on Mar 31, 2025.
Founded in 1849 and headquartered in New York, United States, operations in the pharmaceutical sector are conducted. A variety of products for disease treatments is developed, including a cancer medicine that inhibits tumor blood supply and disrupts cellular reproduction. Chantix is available to support smoking cessation. In 2022, annual revenues reached 92.95 billion, with net profit at 29.04 billion. Leadership is held by CEO Albert Bourla.
Pfizer's top competitors include Merck, Roivant Sciences and AbbVie.
Yes, Pfizer is publicly traded on NSE under the ticker symbol PFIZER.
Pfizer has made 43 acquisitions, including Alacer, Allergan, and Amplyx Pharmaceuticals.
Pfizer has 5 investors. Key investors include Gates Foundation, European Union, Tekla Capital Management, Michigan Economic Development, and NovaQuest Capital Management.
The ticker symbol of Pfizer is PFIZER on NSE.